Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotech, is advancing PP405, its lead candidate for the ...

Healthcare research with the potential to improve patient outcomes is abundant; however, evidence often fails to be promptly ...

London’s King’s Cross tunnel has been illuminated in pink for the first time ever, marking Breast Cancer Awareness Month ...

AI in pharmaceuticals spans blue-sky possibilities to immediate practical applications delivering value today. AI-powered ...

Eli Lilly has appointed Peter Marks, former director of the US Food and Drug Administration’s (FDA) Centre for Biologics ...

AstraZeneca has announced an agreement with the US government aimed at lowering the cost of prescription medicines for ...

Bristol Myers Squibb (BMS) has agreed to acquire Orbital Therapeutics in a deal valued at $1.5bn. Robert Plenge, executive VP ...

Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern ...

The second phase of Precision Oncology Ireland (POI), the country’s largest cancer research programme has been launched by ...

As we discussed in our previous PME article ‘Product launches: making the most of your one shot’, traditional launch planning ...

Standing out requires more than just having a strong product, it demands strategic clarity and operational agility ...

Among the key developments is a move towards greater regulatory alignment between the two agencies. Under the MHRA’s proposed ...